Accessibility Menu

Septerna

(NASDAQ) SEPN

Current Price$24.25
Market Cap$1.09B
Since IPO (2024)+13%
5 YearN/A
1 Year+271%
1 Month-20%

Septerna Financials at a Glance

Market Cap

$1.09B

Revenue (TTM)

$45.95M

Net Income (TTM)

$48.88M

EPS (TTM)

$-1.11

P/E Ratio

-21.82

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$24.25

Volume

13,825

Open

$24.05

Previous Close

$24.25

Daily Range

$23.47 - $24.51

52-Week Range

$4.66 - $32.63

SEPN News

No articles available.

SEPN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Septerna

Industry

Pharmaceuticals

Employees

130

CEO

Jeffrey T. Finer, MD, PhD

Headquarters

South San Francisco, CA 94080, US

SEPN Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-2%

Net Income Margin

-1%

Return on Equity

-12%

Return on Capital

-16%

Return on Assets

-8%

Earnings Yield

-4.58%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.09B

Shares Outstanding

44.91M

Volume

13.82K

Short Interest

0.00%

Avg. Volume

292.18K

Financials (TTM)

Gross Profit

$44.35M

Operating Income

$80.80M

EBITDA

$79.19M

Operating Cash Flow

$110.19M

Capital Expenditure

$518.00K

Free Cash Flow

$109.67M

Cash & ST Invst.

$391.09M

Total Debt

$23.63M

Septerna Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$24.12M

+11276.4%

Gross Profit

$22.51M

+10519.8%

Gross Margin

93.35%

N/A

Market Cap

$1.09B

N/A

Market Cap/Employee

$14.54M

N/A

Employees

75

N/A

Net Income

$10.74M

+48.0%

EBITDA

$15.62M

+35.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$367.46M

+12.9%

Accounts Receivable

$10.36M

+821.4%

Inventory

$0.00

N/A

Long Term Debt

$21.41M

-9.4%

Short Term Debt

$2.21M

+19.5%

Return on Assets

-8.20%

N/A

Return on Invested Capital

-15.87%

N/A

Free Cash Flow

$15.05M

+30.2%

Operating Cash Flow

$14.99M

+28.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EYPTEyePoint Pharmaceuticals, Inc.
$13.79+1.10%
BCAXBicara Therapeutics Inc. Common Stock
$18.79+2.06%
FTREFortrea Holdings Inc.
$9.79-1.51%
NRIXNurix Therapeutics, Inc.
$14.92-0.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
VGVenture Global
$14.29-0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.35+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%

Questions About SEPN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.